| Actionable mutations in pancreatic cancer : where targeted therapies are making a difference | BMJ open gastroenterology |  | | 2025 | 12 | 145 |
|
| Impact of Neoadjuvant Immunotherapy in Localized Rectal Cancer. A Systematic Review | Clinical colorectal cancer | | | 2025 | 24 | 376 |
|
| Cancer du pancréas en 2025 : prise en charge multidisciplinaire | Revue médicale suisse |  | | 2025 | 61 | 0 |
|
| Neoantigen-specific T-cell response after donor lymphocyte infusion associates with favorable outcome in a patient with i(12p) germ cell tumor, acute leukemia and sarcoma of the same clonal origin | Haematologica | | | 2024 | 112 | 97 |
|
| An Overview of Cytokine Release Syndrome and Other Side Effects of CAR-T Cell Therapy | Praxis | | | 2023 | 128 | 0 |
|
| Novel pathophysiological insights into CAR-T cell associated neurotoxicity | Frontiers in neurology | | | 2023 | 178 | 279 |
|
| Challenging Hurdles of Current Targeting in Glioblastoma: A Focus on Immunotherapeutic Strategies | International Journal of Molecular Sciences | | | 2021 | 268 | 487 |
|
| Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma | Journal for immunotherapy of cancer | | | 2021 | 285 | 392 |
|
| Treating ICB-resistant glioma with anti-CD40 and mitotic spindle checkpoint controller BAL101553 (lisavanbulin) | JCI insight | | | 2021 | 270 | 396 |
|
| Improved glioblastoma mouse models to design better immunotherapeutic combinations | | | | 2019 | 666 | 230 |
|
| Responsiveness to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade in SB28 and GL261 mouse glioma models | OncoImmunology | | | 2018 | 441 | 1 |
|
